絞り込み

16644

広告

3355件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Use of Direct Oral Anticoagulants in Morbidly Obese Patients.

Current Strategies for the Management of Bleeding Associated with Direct Oral Anticoagulants and a Review of Investigational Reversal Agents.

Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation.

Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation.

Optimization by response surface methodology of a dispersive magnetic solid phase extraction exploiting magnetic graphene nanocomposite coupled with UHPLC-PDA for simultaneous determination of new oral anticoagulants (NAOs) in human plasma.

Comparing the Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in the Elderly Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.

What's new in the prevention and treatment of cancer-associated thrombosis?

Extended thromboprophylaxis for hip or knee arthroplasty. Does the administration route and dosage regimen affect adherence? A cohort study.

Andexanet alfa for reversal of factor Xa inhibitor-associated anticoagulation.

Intraosseous administration of 4-factor prothrombin complex concentrate prior to emergent surgery after receiving apixaban.

A Very Late and Persistent Thrombosis after Left Atrial Appendage Occlusion.

Permanent His bundle pacing and atrioventricular node ablation in a case with drug-refractory atrial fibrillation.

Thrombin Aptamer-Modified Metal-Organic Framework Nanoparticles: Functional Nanostructures for Sensing Thrombin and the Triggered Controlled Release of Anti-Blood Clotting Drugs.

Newer Oral Anticoagulant in Chronic Kidney Disease: What we Should Know.

Cryptogenic Stroke: Diagnostic Workup and Management.

Practical guide to choosing dabigatran 150 mg twice daily or apixaban 5 mg twice daily for patients with atrial fibrillation.

A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.

Retained coronary guidewire extending to the right axillary artery.

Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Atrial Fibrillation Patients with Concomitant Peripheral Artery Disease.

[A patient with inflammatory arthralgia, paraesthesia and atrial fibrillation].

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります